1
|
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
|
J Rheumatol
|
1988
|
16.45
|
2
|
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.
|
Am J Epidemiol
|
1997
|
6.10
|
3
|
Criteria for the classification of early systemic sclerosis.
|
J Rheumatol
|
2001
|
5.39
|
4
|
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
|
Ann Intern Med
|
2000
|
4.07
|
5
|
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee.
|
Arthritis Rheum
|
1994
|
3.24
|
6
|
Severe organ involvement in systemic sclerosis with diffuse scleroderma.
|
Arthritis Rheum
|
2000
|
3.02
|
7
|
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.
|
Arthritis Rheum
|
1988
|
2.93
|
8
|
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States.
|
J Rheumatol
|
1989
|
2.67
|
9
|
Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study.
|
Arthritis Rheum
|
1994
|
2.41
|
10
|
Incidence of systemic lupus erythematosus. Race and gender differences.
|
Arthritis Rheum
|
1995
|
2.38
|
11
|
Long-term outcomes of scleroderma renal crisis.
|
Ann Intern Med
|
2000
|
2.27
|
12
|
The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.
|
Arthritis Rheum
|
1997
|
2.21
|
13
|
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations.
|
Arthritis Rheum
|
1984
|
2.17
|
14
|
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.
|
Arthritis Rheum
|
1980
|
2.13
|
15
|
Severe restrictive lung disease in systemic sclerosis.
|
Arthritis Rheum
|
1994
|
2.11
|
16
|
Adult-onset Still's disease. Clinical course and outcome.
|
Arthritis Rheum
|
1987
|
2.11
|
17
|
Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.
|
Ann Intern Med
|
1990
|
2.03
|
18
|
Eosinophilic fasciitis. A pathologic study of twenty cases.
|
Am J Pathol
|
1979
|
2.02
|
19
|
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.
|
Ann Intern Med
|
1971
|
2.00
|
20
|
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
|
J Rheumatol
|
1998
|
1.97
|
21
|
Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
|
Arthritis Rheum
|
2000
|
1.97
|
22
|
Raynaud's phenomenon: a proposal for classification.
|
Clin Exp Rheumatol
|
1993
|
1.96
|
23
|
Predictors of survival in systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1991
|
1.94
|
24
|
Epidemiology of systemic sclerosis (scleroderma).
|
Ann Intern Med
|
1971
|
1.93
|
25
|
Autoantibody reactive with RNA polymerase III in systemic sclerosis.
|
Ann Intern Med
|
1993
|
1.91
|
26
|
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.
|
Ann Intern Med
|
1982
|
1.84
|
27
|
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
|
Arthritis Rheum
|
2000
|
1.82
|
28
|
Carpal arthritis with ankylosis in late onset Still's disease.
|
Arthritis Rheum
|
1976
|
1.82
|
29
|
The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis.
|
Arthritis Rheum
|
1997
|
1.78
|
30
|
Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study.
|
Arthritis Rheum
|
1995
|
1.78
|
31
|
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
|
Arthritis Rheum
|
1999
|
1.75
|
32
|
Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.
|
Arthritis Rheum
|
1986
|
1.72
|
33
|
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
|
Ann Rheum Dis
|
2006
|
1.70
|
34
|
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.
|
Arthritis Rheum
|
1982
|
1.62
|
35
|
Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1988
|
1.54
|
36
|
Palmar fasciitis and polyarthritis associated with ovarian carcinoma.
|
Ann Intern Med
|
1982
|
1.51
|
37
|
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death.
|
Arthritis Rheum
|
1982
|
1.51
|
38
|
The epidemiology of polymyositis.
|
Am J Med
|
1970
|
1.50
|
39
|
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.
|
Ann Intern Med
|
1994
|
1.50
|
40
|
The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis.
|
Ann Intern Med
|
1967
|
1.45
|
41
|
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
|
Arthritis Rheum
|
1999
|
1.45
|
42
|
Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
|
Arthritis Rheum
|
1998
|
1.45
|
43
|
Cancer and systemic sclerosis. An epidemiologic study.
|
Arthritis Rheum
|
1985
|
1.45
|
44
|
Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.
|
Medicine (Baltimore)
|
1983
|
1.44
|
45
|
Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
|
Arthritis Rheum
|
1985
|
1.42
|
46
|
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
|
Arthritis Rheum
|
2001
|
1.42
|
47
|
Factors affecting survivorship in polymyositis. A life-table study of 124 patients.
|
Arthritis Rheum
|
1971
|
1.40
|
48
|
Photopheresis for scleroderma? No!
|
J Rheumatol
|
1992
|
1.40
|
49
|
D-penicillamine in the treatment of localized scleroderma.
|
Arch Dermatol
|
1990
|
1.39
|
50
|
Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982.
|
J Rheumatol
|
1990
|
1.37
|
51
|
A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
|
J Rheumatol
|
1990
|
1.35
|
52
|
Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.
|
Arthritis Rheum
|
1984
|
1.35
|
53
|
Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis.
|
Arthritis Rheum
|
1992
|
1.33
|
54
|
Improvement in skin thickening in systemic sclerosis associated with improved survival.
|
Arthritis Rheum
|
2001
|
1.31
|
55
|
Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature.
|
Arthritis Rheum
|
1984
|
1.30
|
56
|
The rheumatic manifestaions of progressive systemic sclerosis (scleroderma).
|
Clin Orthop Relat Res
|
1968
|
1.30
|
57
|
Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study.
|
Am J Med
|
1987
|
1.26
|
58
|
Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.
|
N Engl J Med
|
1984
|
1.26
|
59
|
Factors predicting development of renal involvement in progressive systemic sclerosis.
|
Am J Med
|
1984
|
1.26
|
60
|
Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.
|
J Chronic Dis
|
1973
|
1.24
|
61
|
Isolated diffusing capacity reduction in systemic sclerosis.
|
Arthritis Rheum
|
1992
|
1.23
|
62
|
Epidemiology and natural history of systemic sclerosis.
|
Rheum Dis Clin North Am
|
1990
|
1.23
|
63
|
Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome.
|
Ann Neurol
|
1986
|
1.22
|
64
|
Pulmonary involvement in systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1985
|
1.21
|
65
|
Herpes zoster in systemic lupus erythematosus.
|
J Rheumatol
|
1995
|
1.21
|
66
|
Skeletal muscle involvement in progressive systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1968
|
1.17
|
67
|
Anemia and scleroderma: frequency, causes, and marrow findings.
|
Arch Intern Med
|
1968
|
1.17
|
68
|
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
|
Arthritis Rheum
|
1999
|
1.16
|
69
|
Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.
|
Arthritis Rheum
|
1997
|
1.14
|
70
|
Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.
|
Arthritis Rheum
|
1994
|
1.13
|
71
|
Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.
|
Am Heart J
|
1993
|
1.12
|
72
|
Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
|
Arch Dermatol
|
1987
|
1.11
|
73
|
The toxicity of D-penicillamine in systemic sclerosis.
|
Ann Intern Med
|
1986
|
1.11
|
74
|
Classification criteria for the idiopathic inflammatory myopathies.
|
Curr Opin Rheumatol
|
1997
|
1.10
|
75
|
Approaches for identifying and defining environmentally associated rheumatic disorders.
|
Arthritis Rheum
|
2000
|
1.09
|
76
|
Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III.
|
J Clin Invest
|
1993
|
1.08
|
77
|
Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
|
Arthritis Rheum
|
1992
|
1.07
|
78
|
Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus.
|
Arthritis Rheum
|
1986
|
1.07
|
79
|
Normotensive renal failure in systemic sclerosis.
|
Arthritis Rheum
|
1989
|
1.06
|
80
|
Tryptophan-induced eosinophilia-myalgia syndrome.
|
N Engl J Med
|
1990
|
1.06
|
81
|
Prognostic importance of cardiac arrhythmias in systemic sclerosis.
|
Am J Med
|
1988
|
1.05
|
82
|
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
|
Arthritis Rheum
|
1998
|
1.05
|
83
|
Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1996
|
1.04
|
84
|
Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis.
|
Arthritis Rheum
|
1990
|
1.03
|
85
|
Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma.
|
Chest
|
1983
|
1.03
|
86
|
Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
|
J Rheumatol
|
1996
|
1.03
|
87
|
Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature.
|
Arthritis Rheum
|
1991
|
1.02
|
88
|
Systemic sclerosis secondary to occupational exposure.
|
Am J Med
|
1988
|
1.02
|
89
|
Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
|
Arthritis Rheum
|
1996
|
1.01
|
90
|
Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA.
|
Lupus
|
1995
|
1.01
|
91
|
Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities.
|
Ann Intern Med
|
1986
|
0.99
|
92
|
Risk of malignancy in women with systemic lupus erythematosus.
|
J Rheumatol
|
1995
|
0.98
|
93
|
Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism.
|
Ann Intern Med
|
1981
|
0.98
|
94
|
A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis.
|
Arthritis Rheum
|
1990
|
0.98
|
95
|
Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study.
|
Arthritis Rheum
|
1988
|
0.98
|
96
|
Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant.
|
J Rheumatol
|
1987
|
0.98
|
97
|
Fertility and pregnancy outcome in women with systemic sclerosis.
|
Arthritis Rheum
|
1999
|
0.98
|
98
|
A controlled study of the long-term prognosis of adult Still's disease.
|
Am J Med
|
1995
|
0.97
|
99
|
Conclusion and identification of the core set of variables to be used in clinical investigations.
|
Clin Exp Rheumatol
|
2003
|
0.96
|
100
|
Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA.
|
J Immunol
|
1992
|
0.96
|
101
|
Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
|
J Rheumatol
|
1985
|
0.96
|
102
|
Classification and diagnostic criteria for polymyositis and dermatomyositis.
|
J Rheumatol
|
1995
|
0.95
|
103
|
Cytokine production and serum levels in systemic sclerosis.
|
Clin Immunol Immunopathol
|
1992
|
0.95
|
104
|
Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
|
J Lab Clin Med
|
1986
|
0.94
|
105
|
The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature.
|
Am J Med
|
1985
|
0.94
|
106
|
Hydralazine induced lupus and Sweet's syndrome. Report and review of the literature.
|
J Rheumatol
|
1990
|
0.94
|
107
|
Proceedings: Eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome.
|
Arthritis Rheum
|
1976
|
0.93
|
108
|
T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.
|
J Clin Invest
|
1995
|
0.93
|
109
|
Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
|
Pediatrics
|
1995
|
0.92
|
110
|
Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis.
|
J Immunol
|
1991
|
0.92
|
111
|
Immune complexes in progressive systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1982
|
0.91
|
112
|
The effect of D-penicillamine on pulmonary findings in systemic sclerosis.
|
Arthritis Rheum
|
1985
|
0.91
|
113
|
Surgery for scleroderma of the hand.
|
J Hand Surg Am
|
1987
|
0.91
|
114
|
Trigeminal neuropathy in progressive systemic sclerosis.
|
Am J Med
|
1982
|
0.91
|
115
|
Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.
|
Hum Immunol
|
1994
|
0.90
|
116
|
Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).
|
J Clin Immunol
|
1982
|
0.90
|
117
|
Brachial plexitis mimicking C5 radiculopathy--a presentation of giant cell arteritis.
|
J Rheumatol
|
1983
|
0.89
|
118
|
HLA-DR antigens in progressive systemic sclerosis (scleroderma).
|
J Rheumatol
|
1983
|
0.89
|
119
|
Hypocalcemia associated with metastatic bone disease. A retrospective study.
|
Arch Intern Med
|
1973
|
0.89
|
120
|
Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
|
J Rheumatol
|
2000
|
0.89
|
121
|
Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis.
|
Arthritis Rheum
|
1996
|
0.89
|
122
|
A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis.
|
Arthritis Rheum
|
1995
|
0.89
|
123
|
Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity.
|
Clin Immunol Immunopathol
|
1996
|
0.88
|
124
|
T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
|
J Immunol
|
1995
|
0.88
|
125
|
Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system.
|
Semin Arthritis Rheum
|
1982
|
0.88
|
126
|
High titers of antibodies to single-stranded DNA in linear scleroderma.
|
Arch Dermatol
|
1985
|
0.88
|
127
|
Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.
|
J Am Acad Dermatol
|
1987
|
0.88
|
128
|
Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis.
|
Arthritis Rheum
|
1986
|
0.88
|
129
|
Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.
|
Arthritis Rheum
|
1999
|
0.87
|
130
|
Cutaneous hypoxia in patients with systemic sclerosis (scleroderma).
|
Arch Dermatol
|
1988
|
0.87
|
131
|
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
|
Arthritis Rheum
|
1992
|
0.87
|
132
|
Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study.
|
J Rheumatol
|
1989
|
0.86
|
133
|
HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.
|
Hum Immunol
|
1995
|
0.86
|
134
|
HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
|
Arthritis Rheum
|
1998
|
0.86
|
135
|
Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
|
J Rheumatol
|
1996
|
0.86
|
136
|
The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans.
|
J Chronic Dis
|
1978
|
0.86
|
137
|
The assessment of the patient with systemic sclerosis. Introduction.
|
Clin Exp Rheumatol
|
2003
|
0.86
|
138
|
Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
|
J Rheumatol
|
1988
|
0.86
|
139
|
Systemic sclerosis and malignancy--are they related?
|
J Rheumatol
|
1985
|
0.85
|
140
|
Pregnancy in women with systemic sclerosis.
|
Arthritis Rheum
|
1989
|
0.85
|
141
|
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
|
Rheumatology (Oxford)
|
2001
|
0.85
|
142
|
Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
|
Arthritis Rheum
|
2001
|
0.85
|
143
|
Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
|
Clin Exp Immunol
|
1990
|
0.85
|
144
|
Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma).
|
J Rheumatol
|
1986
|
0.85
|
145
|
Resorption of the mandibular condyles and coronoid processes in progressive systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1981
|
0.84
|
146
|
Serum antibody to retroviral gag proteins in systemic sclerosis.
|
Arthritis Rheum
|
1991
|
0.84
|
147
|
Pasteurella multocida polyarticular septic arthritis.
|
J Rheumatol
|
1987
|
0.84
|
148
|
Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen.
|
Arthritis Rheum
|
1988
|
0.83
|
149
|
Coronary arteritis in systemic lupus erythematosus.
|
Chest
|
1976
|
0.83
|
150
|
A new look at the epidemiology of ankylosing spondylitis and related syndromes.
|
Clin Orthop Relat Res
|
1979
|
0.83
|
151
|
Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type.
|
Arthritis Rheum
|
1988
|
0.83
|
152
|
Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis.
|
J Lab Clin Med
|
1982
|
0.83
|
153
|
Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus.
|
Am J Reprod Immunol
|
1993
|
0.83
|
154
|
The variability of immunologic laboratory tests.
|
J Rheumatol
|
1982
|
0.83
|
155
|
Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins.
|
J Rheumatol
|
2000
|
0.82
|
156
|
Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis.
|
J Rheumatol
|
1982
|
0.82
|
157
|
Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
|
J Immunol
|
1997
|
0.82
|
158
|
Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary?
|
Gastroenterology
|
1985
|
0.82
|
159
|
Serum eosinophilotactic activity in eosinophilic fasciitis.
|
Arthritis Rheum
|
1982
|
0.82
|
160
|
Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma).
|
Ann Rheum Dis
|
1984
|
0.82
|
161
|
Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial.
|
Arthritis Rheum
|
1992
|
0.81
|
162
|
Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.
|
Clin Exp Rheumatol
|
2014
|
0.81
|
163
|
Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome.
|
Arch Intern Med
|
2001
|
0.81
|
164
|
Risk factors for adult Still's disease.
|
J Rheumatol
|
1996
|
0.81
|
165
|
Allergic granulomatous angiitis (Churg-Strauss syndrome).
|
J Allergy Clin Immunol
|
1975
|
0.80
|
166
|
Serum immunoglobulins, rheumatoid factor, and pneumoconiosis in coal miners with rheumatoid arthritis.
|
Arthritis Rheum
|
1976
|
0.80
|
167
|
D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
|
Arthritis Rheum
|
1987
|
0.80
|
168
|
Proceedings: HL-A antigen 27 and psoriatic spondylitis.
|
Arthritis Rheum
|
1974
|
0.80
|
169
|
Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells.
|
J Immunol
|
2000
|
0.79
|
170
|
Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs.
|
J Rheumatol
|
1993
|
0.79
|
171
|
Surgery for ischemic pain and Raynaud's' phenomenon in scleroderma: a description of treatment protocol and evaluation of results.
|
Microsurgery
|
2001
|
0.79
|
172
|
Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma.
|
Am J Med
|
1984
|
0.79
|
173
|
Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements.
|
J Rheumatol
|
1994
|
0.78
|
174
|
Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases.
|
Arthritis Rheum
|
2001
|
0.78
|
175
|
Inflammatory myopathies.
|
Baillieres Clin Rheumatol
|
1995
|
0.78
|
176
|
Consensus statement on the relationship of breast implants to connective-tissue disorders.
|
Plast Reconstr Surg
|
1992
|
0.77
|
177
|
Current management of polymyositis and dermatomyositis.
|
Drugs
|
1989
|
0.77
|
178
|
Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus.
|
Am J Epidemiol
|
1993
|
0.77
|
179
|
Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
|
Diagn Clin Immunol
|
1987
|
0.76
|
180
|
An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
|
Arthritis Rheum
|
1999
|
0.76
|
181
|
Progressive systemic sclerosis.
|
Clin Rheum Dis
|
1983
|
0.76
|
182
|
Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts.
|
J Rheumatol
|
1989
|
0.76
|
183
|
Circulating immune complexes in eosinophilic fasciitis.
|
Arthritis Rheum
|
1982
|
0.76
|
184
|
Severe arthralgias after wide fluctuation in corticosteroid dosage.
|
J Rheumatol
|
1986
|
0.75
|
185
|
Systemic sclerosis (scleroderma) and multiple sclerosis.
|
Arthritis Rheum
|
1986
|
0.75
|
186
|
Microsurgical revascularisation of the hand in scleroderma.
|
Br J Plast Surg
|
1987
|
0.75
|
187
|
We need simple guidelines for reporting rates of rheumatic diseases.
|
Arthritis Rheum
|
1999
|
0.75
|
188
|
Scleromyxedema myopathy: case report and review of the literature.
|
Arthritis Rheum
|
1988
|
0.75
|
189
|
Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.
|
Clin Immunol Immunopathol
|
1995
|
0.75
|
190
|
The Lupus Foundation as an additional source for case ascertainment: developing a community-based lupus registry.
|
Arthritis Care Res
|
2000
|
0.75
|
191
|
Lipid microspherule-associated acute monarticular arthritis.
|
Arthritis Rheum
|
1986
|
0.75
|
192
|
A novel cell-cycle-dependent 350-kDa nuclear protein: C-terminal domain sufficient for nuclear localization.
|
Biochem Biophys Res Commun
|
1995
|
0.75
|
193
|
Response of patients with renal involvement by progressive systemic sclerosis to antihypertensive therapy.
|
Clin Sci (Lond)
|
1981
|
0.75
|
194
|
Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA.
|
Diagn Clin Immunol
|
1987
|
0.75
|
195
|
Wrist drop in progressive systemic sclerosis (scleroderma): complete rupture of the extensor tendon mechanism.
|
Arthritis Rheum
|
1985
|
0.75
|
196
|
Communicating hydrocephalus secondary to diffuse meningeal spread of Wegener's granulomatosis: case report and literature review.
|
Neurosurgery
|
1998
|
0.75
|
197
|
Cholestasis associated with D-penicillamine therapy: case report and review of the literature.
|
Arthritis Rheum
|
1981
|
0.75
|
198
|
Proceedings: Selective carpo-metacarpal arthritis with early ankylosis in adult onset Still's disease.
|
Arthritis Rheum
|
1976
|
0.75
|
199
|
L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.
|
Arthritis Rheum
|
1992
|
0.75
|
200
|
Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange.
|
Scand J Rheumatol
|
2000
|
0.75
|
201
|
Discordance of SSA/Ro and SSB/La cellular antigens in synchronized cells.
|
J Invest Dermatol
|
1986
|
0.75
|